These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33738452)

  • 21. Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family.
    Guilmette J; Dias-Santagata D; Nosé V; Lennerz JK; Sadow PM
    Hum Pathol; 2019 Jan; 83():50-58. PubMed ID: 30130630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity.
    Tognon CE; Mackereth CD; Somasiri AM; McIntosh LP; Sorensen PH
    Mol Cell Biol; 2004 Jun; 24(11):4636-50. PubMed ID: 15143160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands.
    Boon E; Valstar MH; van der Graaf WTA; Bloemena E; Willems SM; Meeuwis CA; Slootweg PJ; Smit LA; Merkx MAW; Takes RP; Kaanders JHAM; Groenen PJTA; Flucke UE; van Herpen CML
    Oral Oncol; 2018 Jul; 82():29-33. PubMed ID: 29909898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of
    Alharbi M; Mobark NA; Balbaid AAO; Alanazi FA; Aljabarat WAR; Bakhsh EA; Ramkissoon SH; Abedalthagafi M
    JCO Precis Oncol; 2020; 4():. PubMed ID: 32923892
    [No Abstract]   [Full Text] [Related]  

  • 25. Sporadic pediatric papillary thyroid carcinoma harboring the ETV6/NTRK3 fusion oncogene in a 7-year-old Japanese girl: a case report and review of literature.
    Otsubo R; Mussazhanova Z; Akazawa Y; Sato A; Matsuda K; Matsumoto M; Yano H; Matsuse M; Mitsutake N; Ando T; Niino D; Nagayasu T; Nakashima M
    J Pediatr Endocrinol Metab; 2018 Mar; 31(4):461-467. PubMed ID: 29427554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
    Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W
    Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
    Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
    Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
    Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
    Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.
    Knezevich SR; Garnett MJ; Pysher TJ; Beckwith JB; Grundy PE; Sorensen PH
    Cancer Res; 1998 Nov; 58(22):5046-8. PubMed ID: 9823307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma in an Adult Population Without Radiation Exposure.
    Seethala RR; Chiosea SI; Liu CZ; Nikiforova M; Nikiforov YE
    Am J Surg Pathol; 2017 Apr; 41(4):446-457. PubMed ID: 28125451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages.
    Lannon CL; Sorensen PH
    Semin Cancer Biol; 2005 Jun; 15(3):215-23. PubMed ID: 15826836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.
    McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR
    Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
    Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
    J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of Entrectinib in a Patient With the First Reported
    Sigal D; Tartar M; Xavier M; Bao F; Foley P; Luo D; Christiansen J; Hornby Z; Maneval EC; Multani P
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1317-1322. PubMed ID: 29118225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful Targeted Therapy of Refractory Pediatric
    Shukla N; Roberts SS; Baki MO; Mushtaq Q; Goss PE; Park BH; Gundem G; Tian K; Geiger H; Redfield K; Behr G; Benayed R; Zehir A; Hechtman JF; Darnell RB; Papaemmanuil E; Ladanyi M; Ku N; Kung AL; Baselga J; Drilon A; Hyman DM
    JCO Precis Oncol; 2017; 2017():. PubMed ID: 29623306
    [No Abstract]   [Full Text] [Related]  

  • 37. Prostatic adenocarcinoma with novel
    Yeh YA; Yang S; Constantinescu M; Chaudoir C; Tanner A; Henry M; Anderson S; Saldivar JS; Serkin F; Fazili T; Lurie AA; Yu X
    Am J Clin Exp Urol; 2019; 7(5):341-345. PubMed ID: 31763365
    [No Abstract]   [Full Text] [Related]  

  • 38. A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation.
    Lannon CL; Martin MJ; Tognon CE; Jin W; Kim SJ; Sorensen PH
    J Biol Chem; 2004 Feb; 279(8):6225-34. PubMed ID: 14668342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off.
    Reynolds S; Shaheen M; Olson G; Barry M; Wu J; Bocklage T
    Head Neck Pathol; 2016 Sep; 10(3):405-13. PubMed ID: 27075025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.